Brief: Biocryst Pharmaceuticals Increases Wholesale Acquisition Cost For Orladeyo To $44,484.33 Per 28-Day Pack
08/01/2025 12:31
Jan 8 (Reuters) - BioCryst Pharmaceuticals Inc BCRX.O :
* BIOCRYST PHARMACEUTICALS INC - INCREASES WHOLESALE
ACQUISITION
COST FOR ORLADEYO TO $44,484.33 PER 28-DAY PACK
Source text: ID:n0001171843-25-000112
Further company coverage: BCRX.O
((Reuters.Brief@thomsonreuters.com))
Recent news on BioCryst Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Pharvaris' genetic disorder drug meets main goal in late-stage trial (updated)
Brief: Biocryst Announces Approval Of Orladeyo® For Pediatric Hae Patients In Japan
BioCryst Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Biocryst Pharmaceuticals, - Cash, Cash Equivalents, Restricted Cash And Investments $354 Million At June 30, 2026